Catalyst Wire Dossier Catalyst Wire Dossier

Stiolto Respimat

tiotropium + olodaterol · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Stiolto Respimat, covering 2015-05-21 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Effects of Tiotropium/Olodaterol on Cardio-pulmonary Exercise Capacity in Patients With Hyperinflated Chronic Obstructive Pulmonary Disease [ACHIEVE] [NA]

See pricing